MILAN (AP) – Russia has struck a deal to develop its own Sputnik V coronavirus vaccine in Italy, its first deal in the European Union, the Russian Chamber of Commerce in Italy said on Tuesday.
The deal was signed with Kirill Dmitri, CEO of Adienne Srl, an Italian subsidiary of the Swiss pharmaceutical company և Russian Direct Investment Fund. Production is scheduled to begin in July, producing 10 million units this year.
“The innovative manufacturing process will help create new jobs, allow Italy to control all production of the compound,” the chamber said in a statement. Financial terms not disclosed.
Russian authorities are working on 20 similar collaborations in Europe,, Sputnik V vaccine has been registered in 45 countries around the world.
The Russian direct investment fund, which has bankrupted the vaccine in foreign markets, has announced that production of Sputnik V will be extended to several countries, including India, South Korea, Brazil, China, Turkey, Iran, as well as Belarus and Kazakhstan. Some manufacturers abroad have produced trial batches of Russian vaccines, but there is little evidence that they have produced large quantities of shots so far.
– Follow AP epidemic coverage https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine և https://apnews.com/Und UndingingtheOutbreak